Brett Kaplan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Emily Pimblett, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brett Kaplan

Form 4 holding Chief Operating Officer

Eliem Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
77,500
Estimated value
$618,450
Report date
26 Aug 2024
Price
$7.98
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Operating Officer

Climb Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
500,000
Estimated value
Report date
13 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Compass Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
30,000
Estimated value
Report date
18 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Brett Kaplan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .